205 related articles for article (PubMed ID: 22915211)
1. Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer.
Perry AS; O'Hurley G; Raheem OA; Brennan K; Wong S; O'Grady A; Kennedy AM; Marignol L; Murphy TM; Sullivan L; Barrett C; Loftus B; Thornhill J; Hewitt SM; Lawler M; Kay E; Lynch T; Hollywood D
Int J Cancer; 2013 Apr; 132(8):1771-80. PubMed ID: 22915211
[TBL] [Abstract][Full Text] [Related]
2. SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.
García-Tobilla P; Solórzano SR; Salido-Guadarrama I; González-Covarrubias V; Morales-Montor G; Díaz-Otañez CE; Rodríguez-Dorantes M
Gene; 2016 Nov; 593(2):292-301. PubMed ID: 27570179
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of SFRPs gene family in cervical cancer.
Chung MT; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Chu TY; Lai HC; Lin YW
Gynecol Oncol; 2009 Feb; 112(2):301-6. PubMed ID: 19038436
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
[TBL] [Abstract][Full Text] [Related]
6. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK
Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950
[TBL] [Abstract][Full Text] [Related]
8. Methylation analysis of SFRP genes family in cervical adenocarcinoma.
Lin YW; Chung MT; Lai HC; De Yan M; Shih YL; Chang CC; Yu MH
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1665-74. PubMed ID: 19513747
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
11. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma.
Takagi H; Sasaki S; Suzuki H; Toyota M; Maruyama R; Nojima M; Yamamoto H; Omata M; Tokino T; Imai K; Shinomura Y
J Gastroenterol; 2008; 43(5):378-89. PubMed ID: 18592156
[TBL] [Abstract][Full Text] [Related]
15. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
[TBL] [Abstract][Full Text] [Related]
16. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
[TBL] [Abstract][Full Text] [Related]
17. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.
Xiao Q; Yang Y; Zhang X; An Q
Tumour Biol; 2016 May; 37(5):6315-21. PubMed ID: 26628297
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.
Suzuki H; Toyota M; Carraway H; Gabrielson E; Ohmura T; Fujikane T; Nishikawa N; Sogabe Y; Nojima M; Sonoda T; Mori M; Hirata K; Imai K; Shinomura Y; Baylin SB; Tokino T
Br J Cancer; 2008 Mar; 98(6):1147-56. PubMed ID: 18283316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
